FindTrial
Sign In

Ticagrelor Placebo

DRUG3 trials

Sponsors

AstraZeneca, Icahn School of Medicine at Mount Sinai

Conditions

AtherothrombosisCardiovascular DeathDiabetes Mellitus, Type 2Myocardial InfarctionPeripheral Artery DiseaseStrokeType 2 Diabetes

Phase 3

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
CompletedNCT01225562
AstraZenecaAtherothrombosis, Cardiovascular Death, Myocardial Infarction +1
Start: 2010-10-31End: 2014-12-31Updated: 2016-01-25
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
CompletedNCT01991795
AstraZenecaDiabetes Mellitus, Type 2
Start: 2014-02-10End: 2019-01-25Updated: 2020-03-18
Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes
CompletedNCT02325466
Icahn School of Medicine at Mount SinaiPeripheral Artery Disease, Type 2 Diabetes
Start: 2015-04-30End: 2018-05-04Updated: 2022-03-21

Related Papers

Polygenic risk score for coronary artery disease across the spectrum of atherosclerotic disease
European Journal of Preventive Cardiology2025-10-27
Statistical approaches for systematically missing covariates in individual participant data meta-analysis: insights and applications using 5 large cardiovascular trials
American Journal of Epidemiology2025-10-08
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis.
2024-04-017 citations
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54
European Heart Journal2022-11-1124 citations
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry.
2022-10-19
Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS
European Heart Journal2022-10-01
Abstract 9330: Machine Learning Can Enable the Automation of Clinical Endpoint Adjudication
Circulation2021-11-16
Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial
Journal of the American Heart Association2021-08-2116 citations
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Journal of the American Heart Association2021-02-0931 citations
Assessment of The High risk and unmEt Need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource use, cost, and burden of illness in a commercially insured population.
2021-01-202 citations
403-P: Impact of Diabetes-Related Factors and Background Antihyperglycemic Therapy on the Efficacy and Safety of Ticagrelor Added to Aspirin: Insights from the THEMIS Trial
Diabetes2020-06-01
Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
2020-05-156 citations
Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry
Endocrinology Diabetes & Metabolism2020-05-078 citations
Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
2020-05-0533 citations
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
European Heart Journal2019-11-0237 citations
2207Cardiovascular outcome in THEMIS -like type 2 diabetes patients in Sweden: a nationwide observational study
European Heart Journal2019-10-011 citations
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
New England Journal of Medicine2019-09-01344 citations
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54
European Heart Journal - Cardiovascular Pharmacotherapy2019-06-1235 citations
Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial
Cardiovascular Diabetology2019-06-0712 citations
Abstract 291: Abstract Title: Assessment of The High risk and unmEt Need in Patients with CAD and Type 2 Diabetes (ATHENA): US Healthcare Resource Use and Cost in a Commercially-Insured Population
Circulation Cardiovascular Quality and Outcomes2019-04-01

16 more papers not shown